EAM
TWST icon

EFG Asset Management’s Twist Bioscience TWST Stock Holding History

EFG Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,537
Closed -$619K – 199
2022
Q1 		$619K Sell
12,537
-6,908
-36% -$383K 0.09% 182
2021
Q4 		$1.51M Buy
+19,445
New +$2M 0.2% 145

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

EFG Asset Management's TWST Position: Q2 2022 in Review

EFG Asset Management sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 12,537 shares — an estimated $619K sold.

EFG Asset Management first reported a position in TWST in Q4 2021 and held it in 2 quarters. The position peaked at $1.51M in Q4 2021. 203 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

  • EFG Asset Management reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
  • EFG Asset Management sold 12,537 Twist Bioscience shares in Q2 2022, an estimated $619K.
  • EFG Asset Management first reported a position in Twist Bioscience in Q4 2021 and held it in 2 quarters.
  • EFG Asset Management's Twist Bioscience position peaked at $1.51M in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on EFG Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.